조직 및 계약 가격을 보려면 로그인를 클릭합니다.
크기 선택
보기 변경
제품정보 (DICE 배송 시 비용 별도)
실험식(Hill 표기법):
C42H76D5NO8
CAS 번호:
Molecular Weight:
733.13
MDL number:
UNSPSC Code:
12352100
NACRES:
NA.25
Assay:
>99% (TLC)
Form:
powder
제품 이름
C18 Glucosyl(β) Ceramide-d5, Avanti Research™ - A Croda Brand 860638P, powder
assay
>99% (TLC)
form
powder
packaging
pkg of 1 × 1 mg (860638P-1mg)
manufacturer/tradename
Avanti Research™ - A Croda Brand 860638P
shipped in
dry ice
storage temp.
−20°C
SMILES string
[H][C@](/C=C/CCCCCCCCCCCC([2H])(C([2H])([2H])[2H])[2H])(O)[C@@]([H])(NC(CCCCCCCCCCCCCCCCC)=O)CO[C@H](O1)[C@H](O)[C@@H](O)[C@@H]([C@H]1CO)O
InChI
1S/C42H81NO8/c1-3-5-7-9-11-13-15-17-18-20-22-24-26-28-30-32-38(46)43-35(34-50-42-41(49)40(48)39(47)37(33-44)51-42)36(45)31-29-27-25-23-21-19-16-14-12-10-8-6-4-2/h29,31,35-37,39-42,44-45,47-49H,3-28,30,32-34H2,1-2H3,(H,43,46)/b31-29+/t35-,36+,37+,39+,40-,4
InChI key
YMYQEDCYNANIPI-PFHCAOQOSA-N
Application
C18 Glucosyl(β) Ceramide-d5 has been used as an internal standard for the quantification of glucosylceramide, in the extracts from mouse cerebellum by liquid chromatography-tandem mass spectrometry.
Packaging
5 mL Amber Glass Screw Cap Vial (860638P-1mg)
Legal Information
Avanti Research is a trademark of Avanti Polar Lipids, LLC
저장 등급
11 - Combustible Solids
wgk
WGK 3
flash_point_f
No data available
flash_point_c
No data available
Victoria Schiffer et al.
PloS one, 15(1), e0227077-e0227077 (2020-01-14)
Gaucher disease is caused by a deficiency in glucocerebrosidase that can result in non-neuronal as well as neuronal symptoms. Common visceral symptoms are an increased organ size, specifically of the spleen, and glucosylceramide as well as glucosylsphingosine substrate accumulations as
국제 무역 품목 번호
| SKU | GTIN |
|---|---|
| 860638P-1MG | 04061835191796 |